pharmaceuticals Article High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on Haemonchus contortus Aya C. Taki 1 , Joseph J. Byrne 1, Tao Wang 1 , Brad E. Sleebs 1,2,3 , Nghi Nguyen 2,3, Ross S. Hall 1, Pasi K. Korhonen 1, Bill C.H. Chang 1, Paul Jackson 4, Abdul Jabbar 1 and Robin B. Gasser 1,* 1 Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC 3010, Australia;
[email protected] (A.C.T.);
[email protected] (J.J.B.);
[email protected] (T.W.);
[email protected] (B.E.S.);
[email protected] (R.S.H.);
[email protected] (P.K.K.);
[email protected] (B.C.H.C.);
[email protected] (A.J.) 2 Chemical Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia;
[email protected] 3 Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia 4 Johnson & Johnson, Global Public Health, Janssen Research and Development, San Diego, CA 92121, USA;
[email protected] * Correspondence:
[email protected] Abstract: Parasitic worms cause very significant diseases in animals and humans worldwide, and their control is critical to enhance health, well-being and productivity. Due to widespread drug resistance in many parasitic worms of animals globally, there is a major, continuing demand for Citation: Taki, A.C.; Byrne, J.J.; the discovery and development of anthelmintic drugs for use to control these worms.